Position in CYTK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,918
+$1,809 QoQ
Shares Held
46
+43.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#431
of 477 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bare Financial Services, Inc holds $305,722 across 81 Biotechnology names. CYTK ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
72 | $26,759 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
78 | $24,654 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
294 | $23,980 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
186 | $22,799 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
398 | $21,865 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
218 | $17,769 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
165 | $9,441 | |
| 8 | INCY |
Incyte Corp
|
83 | $9,408 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,918 | 46 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,109 | 32 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,494 | 55 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||